cp wire

CP Wire Articles

Kaleido Biosciences Raises $101 Million Series C Financing

Kaleido Biosciences, announced on 6/25/2018 that it has closed $101 million in an oversubscribed Series C financing. Several new investors participated in the financing, including a wholly-owned... read more

Tue, 06/26/18 - 02:01 pm
Arcus Biosciences and Infinity Pharmaceuticals Partner to Evaluate Triple-Combination Therapy in Breast and Ovarian Cancer

Arcus Biosciences, Inc. (NYSE:RCUS) and Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) announced on 6/26/2018 that they have entered into a clinical collaboration to evaluate two triple combination... read more

Tue, 06/26/18 - 09:23 am
FDA Approves First Glucose Monitoring System with Fully Implantable Sensor

The FDA approved on 6/21/2018 the Eversense Continuous Glucose Monitoring (CGM) system for use in people 18 years of age and older with diabetes. This is the first FDA-approved CGM system to... read more

Fri, 06/22/18 - 10:27 am
NANOBIOTIX Achieves Primary and Secondary Endpoints in Ph II/III Study in Soft Tissue Sarcoma with NBTXR3
  • Primary endpoint was the pathological Complete Response Rate
  • The main secondary endpoint was the resection margin status evaluating the quality of surgery
  • NBTXR3 accumulates... read more
Fri, 06/22/18 - 10:09 am
The Latest Biotech IPO - $150 million

Autolus Therapeutics plc (“Autolus”) announced on 6/22/2018 the pricing of its initial public offering in the United States of 8,823,530 American Depositary Shares (“ADSs”) representing 8,823,530... read more

Fri, 06/22/18 - 09:41 am

Pages